Stay updated with breaking news from Tolerance Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1
Landmark NIH allergy study shows immunotherapy successfully desensitizes 71% of young children with severe peanut allergy, with 21% also achieving remission.
After 2.5 years of peanut oral immunotherapy, 71% of toddlers could safely consume 17 peanuts, and more than 1 in 5 maintained this protection even after stopping treatment for 6 months.
It's been a year of fabulous stories - join us on a fascinating journey through our most popular stories of the year.
PAUSE results do not support abatacept for treating psoriatic arthritis, psoriasis skin lesions concurrently Treatment with abatacept was not effective in preventing relapse of psoriasis in patients with moderate-to-severe plaque psoriasis who had been treated with ustekinumab, according to results from the PAUSE study. Researchers concluded that psoriasis, therefore, may rely on different pathways to